✦ LIBER ✦

HEPATITIS AND EPIDEMIC HEPATITIS ASSOCIATED ANTIGEN (E.H.A.A.) IN A HÆMODIALYSIS UNIT WITH OBSERVATIONS ON HÆMOGLOBIN LEVELS

✍ Scribed by J. C. Coleman; J. B. Eastwood; J. R. Curtis; R. A. Fox; M. S. Edwards

Book ID: 115191342
Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 503 KB
Volume: 44
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1972.tb10065.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotype C hepatitis B virus infection i

Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline

✍ Chia-Ming Chu; Yun-Fan Liaw 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Immunogenicity of influenza A(H1N1)pdm09

Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C

✍ Satoko Ohfuji; Wakaba Fukushima; Akihiro Tamori; Kazuhiro Maeda; Akiko Maeda; Yo 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 97 KB

Shorter durations and lower doses of peg

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

✍ Y.-F. Liaw; J.-D. Jia; H.L.Y. Chan; K.H. Han; T. Tanwandee; W.L. Chuang; D.M. Ta 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 2 views

As there is currently a lack of consensus on the most appropriate dose and duration of peginterferon alfa-2a (PEG-IFNα-2a) therapy in hepatitis B e antigen (HBeAg)-positive patients, the efficacy and safety of either 24 or 48 weeks' duration and 90 μg/week or 180 μg/week doses were compared. HBeAg-p

Les formes graves de l'hépatite virale A

Les formes graves de l'hépatite virale A : • IR Willner, MD Uhl, SC Howard, EQ Williams, CA Riely, B Waters Serious hepatitis A: An analysis of patients hospitalized during an urban epidemic in the United States Ann Intern Med 1998 ; 128 : 111–4 • S Vento, T Garofano, C Renzini, F Cainelli, F Casali, G Ghironzi, T Ferraro, E Concia Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C N Engl J Med 1998 ; 338 : 286–90

✍ Thierry Zenone 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 330 KB

Observations on an Outbreak of Disease i

Observations on an Outbreak of Disease in Dogs Associated with the Viruses of Both Canine Distemper and Infectious Canine Hepatitis

✍ A. MANTOVANI; G. PICCOLINO; R. RESTANI; D. SCIARRA; L. TAGLIA 📂 Article 📅 1960 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Hepatocellular carcinoma and hepatitis B

Hepatocellular carcinoma and hepatitis B: Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, Krogsgaard K, Degos F, Carneiro De Moura M, Solinas A, Noventa F, Realdi G, EUROHEP Study Group on Hepatitis B Virus and Cirrhosis (Istituto di Semeiotica e Nefrologia Medica, University of Verona, Verona, Italy; Istituto di Medicina Clinica, University of Padova, Padova, Italy; Internal Medicine II, University Hospital Rotterdam, Rotterdam, The Netherlands; Academic Department of Medicine, Hippokration General Hospital, Athens, Greece; Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain; Cattedra di Clinica Medica R, University of Palermo, Palermo, Italy; Department of Medicine B, Bispebjerg University Hospital, Copenhagen, Denmark; University Hospital, Rigshospitalet, Copenhagen, Denmark; Unitè d'Hépatologie, Hôpital Beaujon, Clichy, France; Servico de Medicina II, Medical School of Lisbon, Lisbon, Portugal; and Istituto di Clinica Medica and Istituto di Patologia Speciale Medica, University of Sassari, Sassari, Italy). Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology 1995;21:77–82

✍ Vivek V. Gumaste 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 342 KB